Skip to main content

NASDAQ:CASC Investor Alert: Investigation of Takeover of Cascadian Therapeutics Inc

San Diego, CA -- (SBWIRE) -- 02/05/2018 -- The takeover of Cascadian Therapeutics Inc is under investigation over possible wrongdoing. The investigation was announced for investors, who currently hold NASDAQ:CASC shares, concerning whether the takeover of Cascadian Therapeutics Inc by Seattle Genetics, Inc for $10.00 per share is unfair.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.